<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Stop_TB_Partnership</id>
	<title>Stop TB Partnership - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Stop_TB_Partnership"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Stop_TB_Partnership&amp;action=history"/>
	<updated>2026-04-22T05:17:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Stop_TB_Partnership&amp;diff=6314969&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Stop_TB_Partnership&amp;diff=6314969&amp;oldid=prev"/>
		<updated>2025-02-18T03:48:22Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 03:48, 18 February 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l39&quot;&gt;Line 39:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 39:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{medicine-stub}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{medicine-stub}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;gallery&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;File:StopTBLogo_RGB.svg|Stop TB Partnership Logo&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;File:Stop_TB_Partnership_GDF_programme_in_action.png|Stop TB Partnership GDF Programme in Action&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;File:TB_REACH_in_action.png|TB REACH in Action&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/gallery&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
	<entry>
		<id>https://wikimd.com/index.php?title=Stop_TB_Partnership&amp;diff=5475775&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Stop_TB_Partnership&amp;diff=5475775&amp;oldid=prev"/>
		<updated>2024-03-31T14:30:22Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Stop TB Partnership&amp;#039;&amp;#039;&amp;#039; is an international organization dedicated to the fight against [[tuberculosis]] (TB), a global [[pandemic]] responsible for millions of infections and deaths annually. Established in 2001, the partnership&amp;#039;s mission is to drive forward innovative solutions to reduce TB worldwide, with the ultimate goal of eliminating the disease.&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The Stop TB Partnership operates with a vision to eradicate [[tuberculosis]] as a public health problem. It brings together a broad spectrum of stakeholders, including national governments, donor agencies, non-governmental organizations (NGOs), health care providers, and affected communities. The partnership focuses on mobilizing resources, fostering innovation, and promoting effective strategies and interventions to combat TB.&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
The Stop TB Partnership was launched following the Amsterdam Ministerial Conference on TB and Sustainable Development in 2000. The initiative was supported by the [[World Health Organization]] (WHO) and other key stakeholders in the global health community. Its formation recognized the need for a coordinated international effort to address the challenges posed by tuberculosis, particularly in the context of the [[Millennium Development Goals]].&lt;br /&gt;
&lt;br /&gt;
==Objectives and Strategies==&lt;br /&gt;
The primary objectives of the Stop TB Partnership include:&lt;br /&gt;
* Enhancing access to effective TB treatment and care&lt;br /&gt;
* Promoting research and development of new TB diagnostics, drugs, and vaccines&lt;br /&gt;
* Supporting the development and implementation of innovative health delivery systems&lt;br /&gt;
* Advocating for increased political and financial commitment to TB control&lt;br /&gt;
&lt;br /&gt;
The partnership employs various strategies to achieve these objectives, such as the Global Plan to End TB, which outlines a comprehensive approach to reducing TB incidence and mortality rates.&lt;br /&gt;
&lt;br /&gt;
==Key Initiatives==&lt;br /&gt;
Among the notable initiatives spearheaded by the Stop TB Partnership are:&lt;br /&gt;
* The [[TB REACH]] program, which focuses on innovative TB case finding and treatment approaches&lt;br /&gt;
* The Global Drug Facility (GDF), aimed at improving access to high-quality TB drugs&lt;br /&gt;
* The Challenge Facility for Civil Society, which supports grassroots organizations in TB-affected communities&lt;br /&gt;
&lt;br /&gt;
==Impact==&lt;br /&gt;
The Stop TB Partnership has made significant contributions to global TB control efforts. Its initiatives have helped improve access to TB diagnosis and treatment, reduce the disease&amp;#039;s stigma, and strengthen health systems. However, challenges remain, including drug-resistant TB strains and the need for more effective vaccines.&lt;br /&gt;
&lt;br /&gt;
==Future Directions==&lt;br /&gt;
Looking forward, the Stop TB Partnership aims to intensify its efforts to end the global TB epidemic by 2030, in line with the [[Sustainable Development Goals]]. This includes enhancing collaboration with partners, leveraging new technologies, and advocating for increased funding and political commitment.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Tuberculosis]]&lt;br /&gt;
* [[World Health Organization]]&lt;br /&gt;
* [[Global health]]&lt;br /&gt;
* [[Pandemic]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Health organizations]]&lt;br /&gt;
[[Category:Tuberculosis]]&lt;br /&gt;
[[Category:International medical and health organizations]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>